HOME >> BIOLOGY >> NEWS
NIH panel urges more informed approach to multivitamin/mineral use for chronic disease prevention

An independent panel convened this week by the NIH Office of Medical Applications of Research and the Office of Dietary Supplements assessed the available evidence on the safety and effectiveness of multivitamin/minerals (MVMs). Following two days of expert presentations, public discussion, and panel deliberations, the panel made recommendations regarding certain specific supplements but ultimately concluded that more rigorous scientific research is needed before strong recommendations can be made regarding MVM use to prevent chronic diseases.

The panel released a draft statement of its findings this morning, at the close of the conference. The panel's findings pertain to the generally healthy population, and do not include pregnant women, children, or those with disease. Full text of the panel's draft state-of-the-science statement will be available late today at http://consensus.nih.gov. The final version will be available at the same Web site in four to six weeks.

"Half of American adults are taking MVMs and the bottom line is that we don't know for sure that they're benefiting from them. In fact, we're concerned that some people may be getting too much of certain nutrients," said J. Michael McGinnis, M.D., M.P.P., Senior Scholar with the Institute of Medicine of the National Academy of Sciences, who chaired the panel.

The panel recommended the combined use of calcium and vitamin D supplementation for postmenopausal women to protect bone health. The panel also advocated that anti-oxidants and zinc be considered for use by non-smoking adults with early-stage, age-related macular degeneration, an eye condition that can cause blindness. The panel supports previous recommendations by the CDC that women of childbearing age take daily folate to prevent neural tube defects (birth defects of the brain and spinal cord) in infants. Conversely, it found no evidence to recommend beta carotene supplements,
'"/>

Contact: Kelli Marciel
marcielk@od.nih.gov
301-496-4819
NIH/National Institutes of Health, Office of Disease Prevention
17-May-2006


Page: 1 2 3 4

Related biology news :

1. Not so contoversial anymore -- panel says moderate coffee drinking reduces many risks
2. National panel led by LSU Chancellor releases report on Corps of Engineers
3. NSAIDs modulate biomarker panel for esophageal adenocarcinoma
4. Independent panel to evaluate widely used chemical, Bisphenol A
5. AAAS panel will focus on the impact of livestock production on the planet
6. Independent panel to evaluate genistein or soy formula human development, reproduction risks
7. PITT research integrity panel finds that Dr. Gerald Schatten committed no scientific misconduct
8. Institute for OneWorld Health hosts panels at ASTMH
9. 9/11 panel makes recommendations for DNA-based identification after mass disasters
10. Pall tells FDA panel about blood filtering technology
11. Expert panel offers prelimary report on health effects of assisted reproductive technologies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2020)... , ... February 06, 2020 ... ... research organization (CRO) specializing in complex interventional medical device and pharmaceutical trials, ... Regulatory Strategy. In this newly established role, Dorothy oversees the development and ...
(Date:2/1/2020)... ... , ... Liver cancer, called hepatocellular carcinoma (HCC), occurs each year in more ... is the 5th most common cancer and the 2nd leading cause of cancer deaths. ... of HCC, while China has half of all patients suffering from liver cancer. The ...
(Date:1/29/2020)... Texas (PRWEB) , ... January 29, 2020 , ... ... DNA plasmid, announced it will start production of a DNA vaccine against the ... executed with Inovio Pharmaceuticals. A grant of up to $9 million from the ...
Breaking Biology News(10 mins):
(Date:2/5/2020)... Conn. (PRWEB) , ... February 04, 2020 , ... ... develops tools for characterizing microbiome populations down to the strain level, has announced ... will sell Shoreline Biome’s microbiome kits and other products to companies and research ...
(Date:2/3/2020)... BUDAPEST, Hungary and CAMBRIDGE, Mass. (PRWEB) , ... ... ... headquartered in Budapest with US offices in Cambridge, MA, announce that OmniType, the ... Access Program (EAP) from today. OmniType is a best-in-class product featuring locus-multiplexing and ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics announced an addition ... Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ year commitment ... can extend the accuracy and ease of use of salivary bioscience into infectious ...
(Date:1/24/2020)... ... January 24, 2020 , ... The plastic and reconstructive ... Center in New Jersey epitomize the notion that plastic surgery is much more than ... in popular media. , Over the last 20 years NJ Top Docs, Dr. Andrew ...
Breaking Biology Technology:
Cached News: